tailieunhanh - ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer

Anillin (ANLN), an actin-binding protein required for cytokinesis, has recently been presented as part of a prognostic marker panel in breast cancer. The objective of the current study was to further explore the prognostic and functional value of ANLN as a single biomarker in breast cancer. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN